​

Funding Round

Series G - RareCyte

Series G - RareCyte

Investment Firm

Overview

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Announced Date

Sep 09, 2021

Funding Type

Series G

Highlights

Location

United States, North America

Social

Investor Lead

Arboretum Ventures

Arboretum Ventures

Arboretum Ventures is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorAgilent Technologies
Participant Investor5AM Ventures
Participant InvestorHealthQuest Capital
Participant InvestorF-Prime Capital
Participant InvestorArboretum Ventures

Round Details and Background

RareCyte raised $24000000 on 2021-09-09 in Series G

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 03, 2022
Grant - RareCyte
1-undefined
Jun 27, 2024
Venture Round - RareCyte
9-20.0M
Aug 29, 2017
Venture Round - RareCyte
3-30.0M
Aug 21, 2012
Venture Round - RareCyte
1-undefined

Recent Activity

There is no recent news or activity for this profile.